ResearcherSt. Josef-HospitalActive in the last 2 years
Céline Lugnier
Matched on ORCID iD 0000-0002-2440-6027; OpenAlex author ID A5072242566. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2023: 1 paper · 2024: 2 papers
Papers 3
- Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO … Co-author DOI 10.1007/s00432-024-05954-5↗
- Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany. Co-author DOI 10.1159/000538171↗
- 68Ga-Labeled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the 68Ga-FAPI PET Observational Trial. Co-author DOI 10.2967/jnumed.122.264827↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Anke Reinacher‐Schick · 3 shared papers, 2023–2024 · strength 0.43
- Paper Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a … DOI 10.1007/s00432-024-05954-5↗
- Paper 68Ga-Labeled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the 68Ga-… DOI 10.2967/jnumed.122.264827↗
- Paper Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Panc… DOI 10.1159/000538171↗
- David P. Witte · 2 shared papers, 2023–2024 · strength 0.30
- Paper Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a … DOI 10.1007/s00432-024-05954-5↗
- Paper 68Ga-Labeled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the 68Ga-… DOI 10.2967/jnumed.122.264827↗
- Janna-Lisa Velthaus · 1 shared paper, 2024 · strength 0.15
- Sabrina Sulzer · 1 shared paper, 2024 · strength 0.15
- Stefanie Hegenberg · 1 shared paper, 2024 · strength 0.15
- Annika Kurreck · 1 shared paper, 2024 · strength 0.15
- Heiko Becker · 1 shared paper, 2024 · strength 0.15
- Maximilian Reichert · 1 shared paper, 2024 · strength 0.15
- Timm M. Reißig · 1 shared paper, 2024 · strength 0.15
- Sebastian Lange · 1 shared paper, 2024 · strength 0.15
- Arndt Vogel · 1 shared paper, 2024 · strength 0.15
- Klara Dorman · 1 shared paper, 2024 · strength 0.15
- Georg Beyer · 1 shared paper, 2024 · strength 0.15
- Christoph Benedikt Westphalen · 1 shared paper, 2024 · strength 0.15
- Wolfgang P. Fendler · 1 shared paper, 2023 · strength 0.15
- Waldemar H. Uhl · 1 shared paper, 2023 · strength 0.15
- Kim Magaly Pabst · 1 shared paper, 2023 · strength 0.15
- Ken Herrmann · 1 shared paper, 2023 · strength 0.15
- Lukas Kessler · 1 shared paper, 2023 · strength 0.15
- Jens Thomas Siveke · 1 shared paper, 2023 · strength 0.15
- Ralf‐Dieter Hofheinz · 1 shared paper, 2024 · strength 0.13
- Andrea Tannapfel · 1 shared paper, 2024 · strength 0.13
- Jan Schildmann · 1 shared paper, 2024 · strength 0.13
- Jochen M. Schmitt · 1 shared paper, 2024 · strength 0.13
- Emmanouil Fokas · 1 shared paper, 2024 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.